The findings indicated an elevated expression of EPHB2 in invasive Wilms tumors stages 2–4 compared to stage 1, suggesting that EPHB2 could serve as a marker for the invasive capacity of Wilms tumors [127]. The gene discussed is EPHB2; the disease is Wilms tumor.